Stockscreener 앱 받기
737.45
0.90%
-6.67
시간 외 거래:
737.45
Regeneron Pharmaceuticals Inc 주식(REGN)의 최신 뉴스
Atopic Dermatitis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | GlaxoSmithKline PLC, Nestle SA, Pfizer Inc., Regeneron Pharma, Abbvie - Barchart.com
Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead? - The Globe and Mail
Formycon secures license date for aflibercept biosimilar FYB203 in Europe - The Pharma Letter
Hudson Bay Capital Management LP Sells 31,367 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Groupama Asset Managment Sells 5,169 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Lower LDL Is Better In New ACC/AHA Guidelines, Making The Case For Add-Ons To Statins - Citeline News & Insights
Trading Action: What are the future prospects of Regeneron Pharmaceuticals Inc2026 Volume Leaders & AI Driven Stock Reports - baoquankhu1.vn
Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
Why Regeneron Pharmaceuticals, Inc. (REGN) Crashed On Friday - MSN
Where is Regeneron Pharmaceuticals (REGN) headed according to analysts? - MSN
Here’s what analysts are saying about Regeneron Pharmaceuticals (REGN) - MSN
Caerus Investment Advisors LLC Takes Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire Inc.
BAYRY Reports Positive Data on Kidney Drug in Non-Diabetic CKD - The Globe and Mail
Regeneron: EPS Set to Jump 18% in 2027 as Obesity Bet Reframes the Investment Case - TIKR.com
Holocene Advisors LP Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Brevan Howard Capital Management LP Decreases Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
California Public Employees Retirement System Sells 111,602 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Boothbay Fund Management LLC Buys 1,541 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Behavioral Patterns of REGN and Institutional Flows - Stock Traders Daily
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Regeneron and Sanofi Extend Phase 3 Itepekimab Program in Chronic Sinus Disease - TipRanks
Hamilton Wealth LLC Acquires New Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Gotham Asset Management LLC Increases Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Stock Holdings Lifted by Distillate Capital Partners LLC - MarketBeat
Aquatic Capital Management LLC Trims Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Alliancebernstein L.P. Sells 63,344 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy? - Insider Monkey
Bank of Nova Scotia Boosts Regeneron Pharmaceuticals Holdings - National Today
Capitolis Liquid Global Markets LLC Sells 93,000 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Chevy Chase Trust Holdings LLC Lowers Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Bank of Nova Scotia Raises Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals (REGN) Valuation Check After Recent Share Price Cooling - simplywall.st
Suvretta Capital Management LLC Raises Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by Dodge & Cox - MarketBeat
Cash per share of Regeneron Pharmaceuticals, Inc. – HAM:RGO - TradingView
Game Creek Capital LP Has $2.77 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Tocqueville Asset Management L.P. Sells 6,884 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Hits Day Low of $744 Amid Price Pressure - Markets Mojo
Regeneron Pharmaceuticals Inc Stock (ISIN: US7739031091) Faces Pressure Amid R&D Surge and Margin Sq - AD HOC NEWS
Quadrature Capital Ltd Has $34.31 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Servier to buy Day One Biopharma for $2.5 billion in tumor treatment push - AOL.com
Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
The U.S. Food and Drug Administration (FDA) has officially approved Regeneron Pharmaceuticals' Eylea HD for the treatment of a rare pediatric disease. - Bitget
Quadrant Capital Boosts Regeneron Pharmaceuticals Holdings - National Today
Mackenzie Financial Corp Raises Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Capital Research Global Investors Raises Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making - AOL.com
2 Reasons Regeneron Stock Could Crush the Market for the Next 10 Years - AOL.com
A Look At Regeneron Pharmaceuticals (REGN) Valuation After Positive Obesity Phase 3 Trial Results - Yahoo Finance
Regeneron Science Talent Search: Jericho High senior Ashka Shah recounts experience at finals in D.C. - Newsday
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN) - Seeking Alpha
WINTON GROUP Ltd Grows Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Franklin Resources Inc. Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Richard Bernstein Advisors LLC Sells 2,449 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Legal & General Group Plc Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Capital World Investors Acquires 32,348 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Stock Position Lowered by Capital International Inc. CA - MarketBeat
Capital International Investors Trims Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Capital Group Private Client Services Inc. - MarketBeat
Regeneron Science Talent Search 2026 recognizes America’s top young scientists - Society for Science
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment - The Manila Times
Regeneron Science Talent Search 2026 Recognizes America’s - GlobeNewswire
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative? - simplywall.st
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More ... - Caledonian Record
Jefferies raises Regeneron stock price target on obesity drug data By Investing.com - Investing.com South Africa
0.04%
1.43%
자본화:
|
볼륨(24시간):